Opioid-Induced Constipation Therapy With Naloxegol and Other Laxatives
Movantik (naloxegol) labeling recommends discontinuing all maintenance laxative therapy prior to initiation of naloxegol. [1] Laxatives may be used only as needed if opioid-induced constipation symptoms persist after naloxegol for 3 days. [1]
Concomitant Use With Linzess (Linaclotide)
No direct drug-drug interaction between naloxegol and linaclotide is stated in the naloxegol prescribing information. [1] Use of linaclotide concurrently with naloxegol is not consistent with the requirement to stop maintenance laxative therapy before naloxegol initiation. [1]
Concomitant Use With Bisacodyl
Maintenance laxatives are recommended to be discontinued before starting naloxegol. [1] Bisacodyl use as a maintenance laxative is therefore not aligned with naloxegol labeling during initiation. [1] VA naloxegol criteria state that maintenance laxative therapy should be discontinued before starting naloxegol and may be resumed if opioid-induced constipation symptoms persist after 3 days. [2]
Concomitant Use With “Solace”
“Solace” is not a medication name that can be linked to a specific laxative product from the available prescribing-information citations. [1] Concomitant use depends on whether the “Solace” product functions as a maintenance laxative. [1] Naloxegol labeling indicates that maintenance laxatives should be discontinued prior to starting naloxegol. [1]
Practical Concurrency Threshold
Naloxegol should be started after discontinuation of maintenance laxative therapy. [1] Laxatives can be used as needed if opioid-induced constipation symptoms are suboptimal after 3 days of naloxegol. [1]
Monitoring and Discontinuation Triggers
Monitoring for severe abdominal pain and/or diarrhea after starting naloxegol is recommended. [1] Naloxegol discontinuation is recommended if severe symptoms develop. [1]
Key Medication-Use Implications for the Requested Combination
Concurrent use of naloxegol with Linzess and bisacodyl as standing (scheduled) constipation therapy is not consistent with naloxegol labeling because maintenance laxatives should be stopped before initiation. [1] Scheduled “rescue” use of laxatives is consistent with naloxegol labeling only after an inadequate response after 3 days of naloxegol. [1]
Safety Caveat for Laxative Augmentation
Naloxegol is associated with opioid-withdrawal-like and gastrointestinal adverse effects in some patients. [1] Adding multiple laxatives concurrently increases the likelihood of treatment-limiting diarrhea and abdominal pain, which are specifically monitored for after naloxegol initiation. [1]